ADA Sessions Wrap Up and KOL Insights

As part of HealthDay’s conference coverage, Dr. Matthias Tschöp joins us to share exciting research on the drug Tirzepatide discussed at this year’s American Diabetes Association’s Scientific Session. Dr. Adam Nelson shares details of his research on cardiovascular preventive therapies in type 2 diabetes.

ADA Sessions Wrap Up and KOL Insights


Read this Next
About UsOur ProductsCustom SolutionsHow it’s SoldOur ResultsDeliveryContact UsBlogPrivacy PolicyFAQ